echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > Heilongjiang: 218 drugs are required to reduce prices nationwide!

    Heilongjiang: 218 drugs are required to reduce prices nationwide!

    • Last Update: 2019-12-04
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    The official request 218 drugs declare the lowest price in China ▍ 218 drugs were asked to reduce their prices On December 2, Heilongjiang drug centralized purchase network issued the notice on the price linkage of non selected drugs in the alliance area Heilongjiang said that among the 25 varieties involved in the centralized drug purchase document in the alliance region released by the joint procurement office, other manufacturers of non selected drugs that have been purchased in the centralized drug purchase network of Heilongjiang Province It is necessary to submit the lowest price of the whole country (excluding the price selected in the pilot of centralized purchase and use of drugs organized by the state and the pilot to expand the regional scope) The price difference between specifications and packaging shall be calculated according to the price difference rules (see the end of the list) the list shows that there are 218 drugs that need to declare the lowest price in the country Heilongjiang said that relevant pharmaceutical manufacturers should declare within the prescribed time limit and ensure the authenticity and accuracy of the declaration For enterprises that fail to declare price reduction within the specified time limit (December 2-december 4), the qualification for online trading of corresponding products will be suspended ▍ the price is unified and open The price of the national linkage does not include the 4 + 7 median price The price linkage excludes the price linked to the volume price in other places and leaves room for the next price reduction for the enterprise's volume purchase negotiation The leading group of the State Council on deepening the reform of the medical and health system issued on November 29 "a number of policies and measures on further deepening the reform of the medical and health system with centralized purchase and use of drugs as the breakthrough point", which stated that the national public purchase market for drugs and the multi-party linkage purchase pattern should be established According to the document, relying on the provincial drug centralized procurement platform, we need to build a unified and open drug public procurement market, unify coding, standards and functional specifications, promote the interconnection and resource sharing of drug prices and other related information, and promote the national linkage of drug prices ▍ drug prices have declined in an all-round way Without high volume purchase, not only individual drug prices have been reduced, but also a whole set of centralized purchase mode has been formed Countries that have evaluated drugs organize negotiation and purchase through price negotiation For drugs that fail to pass the consistency evaluation, they will also lower the price by linking the quantity and price That is to say, for drugs that are not included in the scope of centralized procurement and use of national organizations, provinces should learn from the experience of centralized procurement and use of national organizations, adopt independent or cross regional alliances and other ways, increase reform and innovation efforts in the scope of procurement of drugs, shortlist criteria, centralized procurement forms and other aspects, and form a work pattern of mutual promotion between the state and local governments In addition, in the document on several policies and measures to further deepen the reform of the medical and health system with centralized purchase and use of drugs as a breakthrough, it is also encouraged to explore the ways of group purchase, joint purchase of specialized hospitals, joint purchase of medical consortia, etc to form a reasonable price, and to encourage the active participation of non-public medical institutions, social pharmacies, etc In this way, the price of drugs after price reduction will be basically the same across the country, and there is no big price difference between different regions, so pharmaceutical enterprises should make a unified plan for the national market when negotiating Attached:
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.